News & Media: Publication Library

PHYSICIANS AND CLINICIANS SHARE EXPERIENCE WITH THE MEDICAL COMMUNITY EXPLORING THE BENEFITS OF THE RECELL® SYSTEM

With more than 50 publications in professional journals, a wealth of data showcases clinical benefits and cost savings. Expand on topic to explore.

  • Molnar et al. J Burn Care Res. Initial Experience With Autologous Skin Cell Suspension for Treatment of Deep Partial-Thickness Facial Burns. 2020 Mar; iraa037, https://doi.org/10.1093/jbcr/iraa037
  • Larson et al. J Burn Care Res. Treatment of a Full-Thickness Burn Injury With NovoSorb Biodegradable Temporizing Matrix and  RECELL® Autologous Skin Cell Suspension: A Case Series. 2020;41(1):215–219. https://academic.oup.com/jbcr/article/41/1/215/5642499
  • Holmes et al. Burns. Demonstration of the safety and effectiveness of the  RECELL® System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries. 2019 Jun;45(4):772-782. doi: 10.1016/j.burns.2018.11.002 https://pubmed.ncbi.nlm.nih.gov/30578048/
  • Kowal et al. Adv Ther. Cost-Effectiveness of the Use of Autologous Cell Harvesting Device Compared to Standard of Care for Treatment of Severe Burns in the United States. 2019 May 7. doi: 10.1007/s12325-019-00961-2 https://pubmed.ncbi.nlm.nih.gov/31065995/
  • Holmes et al. J Burn Care Res. A Comparative Study of the  RECELL® Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries. 2018 Aug 17;39(5):694-702 https://pubmed.ncbi.nlm.nih.gov/29800234/
  • Wallace et al. Identification of factors predicting scar outcome after burn injury in adults: a prospective case-control study. Burns. 2017; Sep;43(6):1271-1283 https://pubmed.ncbi.nlm.nih.gov/28420569/
  • Johnstone et al. Burns. Successful application of keratinocyte suspension using autologous fibrin spray. 2017;43(3):e27-e30 https://pubmed.ncbi.nlm.nih.gov/27345775/
  • Sood et. al. Wounds. A comparative study of spray keratinocytes and autologous meshed split-thickness skin graft in the treatment of acute burn injuries. 2015 Feb:27(2):31-40 https://pubmed.ncbi.nlm.nih.gov/25785905/
  • Lim et. al. Burns. Is the length of time in acute burn surgery associated with poorer outcomes? 2014;40(2):235-40 https://pubmed.ncbi.nlm.nih.gov/23876784/
  • Park et. al. Burns. Does the type of skin replacement surgery influence the rate of infection in acute burn injured patients? 2013;39(7):1386-90 https://europepmc.org/article/med/23622869
  • O’Neill et. al. Burns. Complex chemical burns following a mass casualty chemical plant incident: how optimal planning and organisation can make a difference. 2012;38(5):713-8 https://pubmed.ncbi.nlm.nih.gov/22356814/
  • Zajicek et. al. Hojeni ran. Healing of widely meshed autografts using freshly isolated autologous epidermal cells and acellular Xe-Derma xenodermis. 2012;6(2):12-8
  • Gravante et. al. Burns. A randomized trial comparing  RECELL® system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. 2007;33(8):966-72 https://pubmed.ncbi.nlm.nih.gov/17904748/
  • Wood et. al. Burns. Characterization of the cell suspension harvested from the dermal epidermal junction using a RECELL® kit. 2012;(38):44-51 https://pubmed.ncbi.nlm.nih.gov/22079538/
  • Graham et al. Toxicology. Medical management of cutaneous sulfur mustard injuries. 2009;263(1):47-58. https://pubmed.ncbi.nlm.nih.gov/18762227/
  • Wood et. al. The use of a non-cultured autologous cell suspension and Integra® dermal regeneration template to repair full-thickness skin wounds in a porcine model: A one-step process. 2007;33(6):693-700 https://pubmed.ncbi.nlm.nih.gov/17485177/
  • Navarro et al. Journal of Burn Care & Rehabilitation. Melanocyte Repopulation in Full-Thickness Wounds Using a Cell Spray Apparatus. 2001;22(1):41-6. https://pubmed.ncbi.nlm.nih.gov/11227683
  • Navarro et. al. J Burn Care & Res. Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model. 2000;21(6):513-8 https://pubmed.ncbi.nlm.nih.gov/11194804/
  • Stoner et al. Journal of Investigative Dermatology. Cultured epithelial autograft “take” confirmed by the presence of Cytokeratin 9. 1999;112(3):391-2
  • Hammer et. al. J Tissue Eng Regen Med. Restoring full-thickness defects with spray skin in conjunction with dermal regenerative template and split-thickness skin grafting: a pilot study. 2017 Dec;11(12):3523-3529 https://pubmed.ncbi.nlm.nih.gov/28326683/
  • Valerio et. al. Plast Reconstr Surg Glob. A case report of the first nonburn-related military trauma victim treated with spray skin regenerative therapy in combination with a dermal regenerate template. 2016;4:e1174 https://pubmed.ncbi.nlm.nih.gov/28293522/
  • Wallace et. al. Burns & Trauma. Identification of factors predicting scar outcome after burn injury in children: a prospective case-control study. 2017; 5:19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494810/
  • Wood et. al. Burns. A prospective randomised clinical pilot study to compare the effectiveness of Biobrane® synthetic wound dressing, with or without autologous cell suspension, to the local standard treatment regimen in paediatric scald injuries. 2012;38(6):830-9 https://pubmed.ncbi.nlm.nih.gov/22322141/
  • Dunne et. al. Burns. Early paediatric scald surgery – A cost effective dermal preserving surgical protocol for all childhood scalds. 2014;40(4):772-778 https://pubmed.ncbi.nlm.nih.gov/24333011/
  • Nanassy et al. The Use of an Autologous Cell Harvesting and Processing Device to Decrease Surgical Procedures and Expedite Healing in Two Pediatric Burn Patients. Wounds. 2019 Dec;31(12):316-321 https://pubmed.ncbi.nlm.nih.gov/31833837/
  • Campanella et. al. A randomised controlled pilot study comparing Mepitel® and Surfasoft® on paediatric donor sites treated with RECELL®. Burns. 2011;37(8): 1334-42 https://pubmed.ncbi.nlm.nih.gov/21982622/
  • Hu et. al. Randomized clinical trial of autologous skin cell suspension for accelerative re-epithelialization of split-thickness donor sites. Br J Surg. 2017 Jun;104(7):836-842 https://pubmed.ncbi.nlm.nih.gov/28379607/
  • Cervelli et. al. Clin Exp Dermatol. Use of a novel autologous cell-harvesting device to promote epithelialization and enhance appropriate pigmentation in scar reconstruction. 2010 Oct;35(7):776-80 https://pubmed.ncbi.nlm.nih.gov/19958370/ 
  • Busch et. al. Combination of medical needling and non-cultured autologous skin cell transplantation (ReNovaCell™) for repigmentation of hypopigmented burn scars. 2016 Nov;42(7):1556-1566 https://pubmed.ncbi.nlm.nih.gov/27156803/
  • Lim et. al. Burns. Long term sensory function after minor partial thickness burn: A pilot study to determine if recovery is complete or incomplete. 2014; 40: 1538-1543 https://pubmed.ncbi.nlm.nih.gov/24767141/
  • Zeng et. al. Zhonghua Zheng Xing Wai Ke Za Zhi. A novel treatment for facial acne scars: dermabrasion combined with RECELL® (skin active cell transplantation) technique. 2014. 30(6): p.417-20 https://pubmed.ncbi.nlm.nih.gov/25895293/
  • Yu et. al. Chin Med Sci J. Effect of Dermabrasion and RECELL® on Large Superficial Facial Scars Caused by Burn, Trauma, and Acnes. 2016 Sep 20;31(3):173-179 https://pubmed.ncbi.nlm.nih.gov/27733225/
  • Goodman et. al. Dermatol Surg. An automated autologous cell transplantation method for the treatment of hypopigmented Scarring. 2008 Apr;34(4):578-81 https://pubmed.ncbi.nlm.nih.gov/18248485/
  • Gramlich et. al. Kosmetische Medizin. Laser rejuvenation in combination with autologous cell suspension. 2010;1(10):25-9
  • Ren et al. The use of noncultured regenerative epithelial suspension for improving skin color and scars: A report of 8 cases and review of the literature. J Cosmet Dermatol. 2019 Jul 26. doi: 10.1111/jocd.13071. https://pubmed.ncbi.nlm.nih.gov/31347758/
  • Chen et al. Aesthetic Plastic Surgery. The Clinical Efficacy of RECELL® Autologous Cell Regeneration Techniques Combined with Dermabrasion Treatment in Acne Scars. 2019 Aug. https://pubmed.ncbi.nlm.nih.gov/31451856/
  • Cervelli et al. Acta Dernatovenerol Croat. Treatment of stable vitiligo by RECELL® System. 2009;17(4):273-278. https://pubmed.ncbi.nlm.nih.gov/20021980/
  • Cervelli et al. European Review for Medical and Pharmacological Sciences. Treatment of stable vitiligo hands by RECELL® system: a preliminary report. 2010;14(8):691-4 https://pubmed.ncbi.nlm.nih.gov/20707289/
  • Komen et. al. J Am Acad Dermatol. Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study. 2015 Jul;73(1):170-2 https://pubmed.ncbi.nlm.nih.gov/26089056/
  • Lommerts et. al. BJ Dermatol. Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO2 laser recipient-site preparations. 2017;177:1293-1298. https://pubmed.ncbi.nlm.nih.gov/28403523/ 
  • Mulekar et. al. Br J Dermatol. Treatment of vitiligo lesions by RECELL® vs conventional melanocyte keratinocyte transplantation: a pilot study. 2008 Jan;158(1):45-9 https://pubmed.ncbi.nlm.nih.gov/17927795/
  • Komen et al. J Cutan Aesthet Surg. Observations on CO2 laser preparation of recipient site for noncultured cell suspension transplantation in vitiligo. 2016 Apr-Jun;9(2):133-5. doi: 10.4103/0974-2077.184055 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924413/
  • Liu et al. J Dermatolog Treat. The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patients. 2019 May 31:1-5. https://pubmed.ncbi.nlm.nih.gov/31084382/
  • Uitentuis et al. Clin Exp Dermatol. Impact of graft cell density and viability on repigmentation upon noncultured autologous cell suspension transplantation in vitiligo and piebaldism. 2020 Apr 20. doi: 10.1111/ced.14249 https://onlinelibrary.wiley.com/doi/abs/10.1111/ced.14249
  • Liu et al. Dermatologic Surgery. New Pigmentation after Medical Treatment Suggests Increased Efficacy of Dermabrasion and Non-cultured Epidermal Cell Suspension Techniques in Stable Vitiligo. 2020 https://pubmed.ncbi.nlm.nih.gov/33038103/

Caution: The safety and effectiveness of RECELL® has not been established for indications in the United States aside from the treatment of acute thermal burns. Other applications are limited by U.S. law to investigational use.

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.